The factors and mechanisms affecting the sensitivity of antitumor drugs are complex and diverse but results from the analysis of the K-M survival plot revealed that the higher expression group of TCF19 was significantly linked with a shorter prognosis for cancer patients. The gene discussed is TCF19; the disease is cancer.